TenNor Therapeutics (Suzhou) Ltd research brief

CIK 2136090 Copy CIK

Generated Nov. 7, 2026, 5:30 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: SUZHOU F4. Reported legal jurisdiction: CHINA. These do not establish investor residence or where funds were deployed.

• May 26, 2026 · D · 0001104659-26-066134 · Source evidence

  Reported offering amount: 14699667 USD. Reported amount sold: 14699667 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “TenNor Therapeutics (Suzhou) Ltd research brief,” CIK 2136090, retrieved Nov. 7, 2026, 5:30 p.m.. Cite the specific accessions used. No amounts have been summed.